Corante

About this Author
Derek Lowe
Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
MedChem Buzz
Kilomentor
On Pharma
A New Merck, Reviewed
Liberal Arts Chemistry
One in Ten Thousand
Electron Pusher
Periodic Tabloid
All Things Metathesis
C&E News Blog
Propter Doc
Chemiotics II
The Chemical Notebook
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
Chirality
BBSRC/Douglas Kell
ChemBark
Drug Discovery Opinion
Realizations in Biostatistics
Chemjobber
Pharmalot
WSJ Health Blog
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Useful Chemistry
Chiral Jones
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Totally Synthetic
Fragment Literature
The F- Blog
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Carbon-Based Curiosities
Experimental Error
Business|Bytes|Genes|Molecules
Eye on FDA
Sigma-Aldrich ChemBlogs
Chemical Forums
Depth-First
Symyx Blog
P212121
ChemCafe
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
A Scientist's Life
Speculist
Cosmic Variance
The Capsule
Zeroth Order Approximation
Biology News Net


Medical Blogs
Med Tech Sentinel
DB's Medical Rants
Science-Based Medicine
GruntDoc
The Health Care Blog
Respectful Insolence
Black Triangle
Diabetes Mine


Economics and Business
Marginal Revolution
Arnold Kling
The Volokh Conspiracy
Knowledge Problem
The Stalwart


Politics / Current Events
Virginia Postrel
Tinkerty Tonk
Instapundit
Megan McArdle
Mickey Kaus
Colby Cosh
Alien Corn
No Watermelons


Belles Lettres
Two Blowhards
Critical Mass
Arts and Letters Daily
God of the Machine
Armavirumque
About Last Night
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« The Latest Technology | Main | If You're Not Excited, Sit Down »

October 25, 2010

Lorcaserin's Complete Response

Email This Entry

Posted by Derek

Arena released their complete response from the FDA over the weekend, regarding the non-approval of their weight loss drug Lorcaserin. And the arguing has already started about just how bad the news is. There are several levels that this process could be tracking on, and we just don't know which one it's on yet.

And the varied regulatory paths that result give you answers to "When will the drug be approved" ranging from "Maybe in six months" through "Maybe in a year" on out to "Maybe in a few years", which at that point shades into "Never". One of the main sticking points is the carcinogenicity data from the animal studies - the FDA is worried, and they want Arena to round up some outside experts to go over the data to address their concerns. Problem is, we don't quite know what that means. It could be anything from "Have some people assure that FDA that everything's actually fine" (the Arena bull position) to "Go run a bunch more long clinical trials" (which is one of the bear positions). I think it's unlikely that the FDA will let the company go through without at least running more rodent studies; I just can't see an outside review of the data doing enough to calm them down. The agency, I believe, is in more of a "Get some people to help you design some good studies" mode.

Matthew Herper's take seems reasonable to me. As he points out, even when companies have gotten a drug through after one of these Complete Response Letters, it's taken at least seven months when the issues didn't involve the clinic. He seems to be taking flak from Arena investors who have loarcaserin penciled in for somewhere around Valentine's Day. But I don't see how that's going to happen, either. Try April Fool's - of some other year.

Comments (7) + TrackBacks (0) | Category: Diabetes and Obesity | Regulatory Affairs


COMMENTS

1. Hap on October 25, 2010 11:52 AM writes...

Small-company pharma investments - because you get home from work too late to watch soap operas on TV and get sick on roller coasters.

Permalink to Comment

2. glinkst on October 25, 2010 9:17 PM writes...

No matter what the FDA's response is, the Arena bulls will be adamant that approval is just around the corner, and that the rest of the world are complete idiots.
It is curious that none of them are calling for the CEO's head. It is all about drinking the kool-aid.
G

Permalink to Comment

3. BbooooooyA on October 25, 2010 9:58 PM writes...

No smart money in arna, bunch of retail pump dumpers.

Great to be on this roller coaster if you know which way it's going

Permalink to Comment

4. DCRogers on October 26, 2010 2:32 PM writes...

Let the lawsuits begin!

My Google ad when I went to look at the stock price (brutal 3M graph, BTW -- latest news "only" knocked off 5% more equity value):

Did you lose money investing in ARNA? Legal investigation.
www.girardgibbs.com/arena.asp

Permalink to Comment

5. Liza Twisdale on March 1, 2012 3:07 PM writes...

I might also like to convey that most people that find themselves devoid of health insurance can be students, self-employed and people who are out of work. More than half of the uninsured are really under the age of Thirty-five. They do not feel they are requiring health insurance simply because they're young as well as healthy. The income is frequently spent on housing, food, as well as entertainment. Most people that do work either whole or part time are not made available insurance via their work so they head out without because of the rising price of health insurance in the United States. Thanks for the thoughts you discuss through this web site.

Permalink to Comment

6. Mariette Gadbury on May 11, 2012 4:21 AM writes...

Thanks for your own labor on this blog. My daughter loves going through research and it's easy to understand why. A lot of people notice all of the lively way you present functional steps via your web blog and in addition welcome response from website visitors on this subject matter so my daughter is truly being taught a great deal. Enjoy the rest of the new year. You're the one performing a tremendous job.

Permalink to Comment

7. Mack Nicastro on May 11, 2012 4:21 AM writes...

After study a number of of the weblog posts in your web site now, and I actually like your way of blogging. I bookmarked it to my bookmark web site list and will probably be checking back soon. Pls take a look at my website as effectively and let me know what you think.

Permalink to Comment

POST A COMMENT




Remember Me?



EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
The World of Metal-Catalyzed Couplings
Arena and Lorcaserin, Back at the FDA
The UK Goes Open-Access
GSK Goes Hostile
One More on That Buckyball Longevity Paper
More Reaction Discovery (Now With Antibody Detection)
PhDs On Food Stamps?
Laboratory Crime, Not Paying